Moreover, SFN combination with anti-cancer agents modulated various tumor suppressors, cyclins, MMPs, cadherins, anti-oxidant enzymes, stem cell markers, apoptotic regulators, etc., which lead to enhanced therapeutic outcomes of chemotherapeutics in cancer models both in vitro and in vivo. This evidence concerns the gene CDH17 and neoplasm.